Different clinical phenotypes in monozygotic cadasil twins with a novel notch3 mutation

Stroke

Volumn 40, Issue 6, 2009, Pages 2215-2218

  Mykkänen, Kati ^a,e   Junna, Maija ^a   Amberla, Kaarina ^b   Bronge, Lena ^c   Kääriäinen, Helena ^a,d   Pöyhönen, Minna ^e   Kalimo, Hannu ^e,f,g   Viitanen, Matti ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UPPSALA UNIVERSITY   (Sweden)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

CADASIL; NOTCH3 monozygotic twins

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; HOMOCYSTEINE; NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN;

ARTICLE; BRAIN DISEASE; CADASIL; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE; HUMAN; HYPERCHOLESTEROLEMIA; IMAGE ANALYSIS; LIFESTYLE; LOW DRUG DOSE; MALE; MONOZYGOTIC TWINS; NEUROIMAGING; NOTCH3 GENE; PHENOTYPE; PHYSICAL ACTIVITY; POLYCYTHEMIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STROKE; SYMPTOM; ADULT; BLOOD; COGNITION; GENETICS; GLUCOSE BLOOD LEVEL; LETTER; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; TWINS;

ADULT; BLOOD GLUCOSE; CADASIL; COGNITION; HOMOCYSTEINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, NOTCH; TWINS, MONOZYGOTIC;

EID: 66849099874     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.528661     Document Type: Article

References (25)

1. 1. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707-710.
2. Arboleda-Velasquez JF, Lopera F, Lopez E, Frosch MP, Sepulveda-Falla D, Gutierrez JE, Vargas S, Medina M, Martinez De Arrieta C, Lebo RV, Slaugenhaupt SA, Betensky RA, Villegas A, Arcos-Burgos M, Rivera D, Restrepo JC, Kosik KS. C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology. 2002;59:277-279.
3. Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004;127:2533-2539.
4. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol. 1998;44:731-739.
5. Brickell KL, Leverenz JB, Steinbart EJ, Rumbaugh M, Schellenberg GD, Nochlin D, Lampe TH, Holm IE, Van Deerlin V, Yuan W, Bird TD. Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2007;78:1050-1055.
6. Anderson JH, Christova PS, Xie TD, Schott KS, Ward K, Gomez CM. Spinocerebellar ataxia in monozygotic twins. Arch Neurol. 2002;59:1945-1951.
7. Gomez-Esteban JC, Lezcano E, Zarranz JJ, Velasco F, Garamendi I, Perez T, Tijero B. Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms. Eur Neurol. 2007;57:26-30.
8. Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powell JF. Diagnostic strategies in CADASIL. Neurology. 2002;59:1134-1138.
9. Lesnik Oberstein SAJ Diagnostic strategies in CADASIL. Neurology. 2003;60:2020; author reply 2020.
10. Vikelis M, Papatriantafyllou J, Krageorgiou CE. A novel CADASIL- causing mutation in a stroke patient. Swiss Med Wkly. 2007;137:323-325.
11. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005;102:10604-10609.
12. Mykkanen K, Savontaus ML, Juvonen V, Sistonen P, Tuisku S, Tuominen S, Penttinen M, Lundkvist J, Viitanen M, Kalimo H, Poyhonen M. Detection of the founder effect in Finnish CADASIL families. Eur J Hum Genet. 2004;12:813-819.
13. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain. 2004;127:2031-2038.
14. Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T, Qiu J, Amin-Hanjani S, Huang PL, Liao JK, Lo EH, Moskowitz MA. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:722-729.
15. Hu FB, Stampfer MJ, Colditz GA, Ascherio A, Rexrode KM, Willett WC, Manson JE. Physical activity and risk of stroke in women. JAMA. 2000; 283:2961-2967.
16. Wechsler D. Wechsler Adult Intelligence Scale, Revised. New York: Hartcourt Brace, Jovanovich; 1981.
17. Spreen O, Benton AL. Neurosensory Center Comprehensive Examination for Aphasia. Victoria, BC: University of Victoria Neuropsychological Laboratory; 1977.
18. Spreen O, Strauss E. A Compendium of Neuropsychological Tests. New York: Oxford University Press; 1991.
19. Christensen AL. Lurias Neuropsychological Investigation. Copenhagen: Munksgaard; 1979.
20. Rey A. L'examen psychologique dans les cas d'encephalopathie trau- matique. Archives de Psychologie. 1941;28:286-340.
21. Lezak M. Neuropsychological Assesment. New York: Oxford University Press; 1995.
22. Wahlin Å, Bäckman L, Winblad B. Free recall and recognition of slowly and rapidly presented words in very old age: A community based study. Exp Aging Res. 1995;21:251-271.
23. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2:200-215.
24. van Swieten JC, Koudstaal PJ, VisserMC, Schouten HJ, van Gijn J. Inter- observer agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
25. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci. 1993;114:7-12.